Candel Therapeutics Inc

NASDAQ:CADL  
3.57
-0.13 (-3.51%)
Earnings Announcements

Candel Therapeutics Reports Q2 Results

Published: 09/08/2021 12:31 GMT
Candel Therapeutics Inc (CADL) - Candel Therapeutics Reports Second Quarter 2021 Financial Results and Recent Corporate Highlights.
Revenue is expected to be $0.01 Million
Adjusted EPS is expected to be -$0.32

Next Quarter Revenue Guidance is expected to be $0.01 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.